What is a stock summary page? Click here for an overview.
Business Description
Ocular Therapeutix Inc
NAICS : 325412
SIC : 2834
ISIN : US67576A1007
Description
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.17 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -0.43 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.24 | |||||
| Beneish M-Score | -2.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.7 | |||||
| 3-Year EPS without NRI Growth Rate | 18.6 | |||||
| 3-Year FCF Growth Rate | -1.9 | |||||
| 3-Year Book Growth Rate | 20.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 30.65 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.51 | |||||
| 9-Day RSI | 53.29 | |||||
| 14-Day RSI | 51.2 | |||||
| 3-1 Month Momentum % | -17.19 | |||||
| 6-1 Month Momentum % | -14.05 | |||||
| 12-1 Month Momentum % | -20.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.66 | |||||
| Quick Ratio | 10.59 | |||||
| Cash Ratio | 9.48 | |||||
| Days Inventory | 167.01 | |||||
| Days Sales Outstanding | 166.78 | |||||
| Days Payable | 294.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.2 | |||||
| Shareholder Yield % | -26.33 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 91.17 | |||||
| Operating Margin % | -269.58 | |||||
| Net Margin % | -303.67 | |||||
| FCF Margin % | -213.3 | |||||
| ROE % | -62.66 | |||||
| ROA % | -42.88 | |||||
| ROIC % | -607.62 | |||||
| 3-Year ROIIC % | -890.26 | |||||
| ROC (Joel Greenblatt) % | -680.62 | |||||
| ROCE % | -43.06 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 18.83 | |||||
| PB Ratio | 3.81 | |||||
| Price-to-Tangible-Book | 3.81 | |||||
| EV-to-EBIT | -4.91 | |||||
| EV-to-EBITDA | -5.02 | |||||
| EV-to-Revenue | 13.88 | |||||
| EV-to-Forward-Revenue | 12.73 | |||||
| EV-to-FCF | -6.74 | |||||
| Price-to-GF-Value | 2.25 | |||||
| Price-to-Median-PS-Value | 0.27 | |||||
| Price-to-Net-Current-Asset-Value | 4.03 | |||||
| Price-to-Net-Cash | 4.82 | |||||
| Earnings Yield (Greenblatt) % | -20.36 | |||||
| FCF Yield % | -11.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ocular Therapeutix Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 59.077 | ||
| EPS (TTM) (€) | -1.168 | ||
| Beta | 0.64 | ||
| 3-Year Sharpe Ratio | 0.49 | ||
| 3-Year Sortino Ratio | 1.09 | ||
| Volatility % | 72.51 | ||
| 14-Day RSI | 51.2 | ||
| 14-Day ATR (€) | 0.232981 | ||
| 20-Day SMA (€) | 6.9414 | ||
| 12-1 Month Momentum % | -20.76 | ||
| 52-Week Range (€) | 3.872 - 10.805 | ||
| Shares Outstanding (Mil) | 159.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ocular Therapeutix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ocular Therapeutix Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ocular Therapeutix Inc Frequently Asked Questions
What is Ocular Therapeutix Inc(STU:0OT)'s stock price today?
The current price of STU:0OT is €7.08. The 52 week high of STU:0OT is €10.81 and 52 week low is €3.87.
When is next earnings date of Ocular Therapeutix Inc(STU:0OT)?
The next earnings date of Ocular Therapeutix Inc(STU:0OT) is 2025-05-07 Est..
Does Ocular Therapeutix Inc(STU:0OT) pay dividends? If so, how much?
Ocular Therapeutix Inc(STU:0OT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers